Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

02. April 2013 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2012 Financial Results

CORAL GABLES, Fla., April 2, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel...
27. März 2013 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Announces Recommendation of Data Monitoring Committee for Pivotal Phase lll Clinical Trial for Firdapse(TM)

CORAL GABLES, Fla., March 27, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on the development and commercialization of...
07. März 2013 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners to Present at 25th Annual ROTH Conference

CORAL GABLES, Fla., March 7, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that Patrick J. McEnany, Catalyst's Chief Executive Officer, and Steven...
05. März 2013 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Appoints Dr. Bernardino Mosquera as Vice President of Clinical Operations

CORAL GABLES, Fla., March 5, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel...
21. Februar 2013 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Launches New Website

CORAL GABLES, Fla., Feb. 21, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel...
11. Februar 2013 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Provides Update on Research and Development Pipeline

CORAL GABLES, Fla., Feb. 11, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel...
05. Februar 2013 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners to Present at 15th Annual BIO CEO & Investor Conference

CORAL GABLES, Fla., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that the company will present at the 15th Annual BIO CEO & Investor...
27. Dezember 2012 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Receives Guidance From NASDAQ Regarding Minimum Bid Price Requirement

CORAL GABLES, Fla., Dec. 27, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that it received a Nasdaq Staff Deficiency Letter, dated December 24, 2012,...
11. Dezember 2012 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Announces Automatic Conversion of $5 Million Promissory Note Into Shares of Common Stock

CORAL GABLES, Fla., Dec. 11, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced that it has issued 6,666,667 shares (the "Shares") of its authorized but...
15. November 2012 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Announces Third Quarter 2012 Financial Results

CORAL GABLES, Fla., Nov. 15, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced its financial results for the third quarter and nine months ended September...

Vorherige Seite